Pharmacodynamics of alcohol: Substantial differences in skills impairment.

被引：0
作者：
Ellinwood, EH
Gupta, SK
Muir, KT
Powell, JR
机构：
[1] DUKE UNIV, DURHAM, NC USA
[2] GLAXO WELCOME INC, RES TRIANGLE PK, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1996年 / 59卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：OIIB4 / OIIB4
页数：1
相关论文
共 50 条
[41]   Family behavioral change following neurologic impairment. [J].
Johnson, DJ .
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1998, 13 (01) :115-116
[42]   Care provision for post stroke visual impairment. [J].
Rowe, F. J. ;
Walker, M. ;
Rockliffe, J. ;
Pollock, A. ;
Noonan, C. P. ;
Howard, C. ;
Hepworth, L. ;
Glendinning, R. ;
Currie, J. .
CEREBROVASCULAR DISEASES, 2014, 37 :62-62
[43]   Neuropathologic features in subjects with mild cognitive impairment. [J].
Parisi, JE ;
Dickson, DW ;
Johnson, KA ;
Ivnik, RJ ;
Smith, GE ;
Tangalos, EG ;
Boeve, BF ;
Kokmen, E ;
Petersen, RC .
BRAIN PATHOLOGY, 2000, 10 (04) :620-620
[44]   Considerations on age-associated memory impairment. [J].
FoussardBlanpin, O ;
Moreau, S ;
Nsabiyumva, F .
SEMAINE DES HOPITAUX, 1996, 72 (21-22) :686-698
[45]   Cerebral hypoxia as a disease model for cognitive impairment. [J].
van der Post, J ;
Noordzij, LAW ;
Blauw, GJ ;
de Kam, ML ;
Pieters, MSM ;
Cohen, AF ;
van Gerven, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) :P79-P79
[46]   Components of Geriatric Depression and types of cognitive impairment. [J].
Hall, J. R. ;
Davis, T. ;
Cornwell, S. L. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) :S102-S102
[47]   Eribulin mesylate pharmacokinetics in patients with hepatic impairment. [J].
Witteveen, P. ;
Marchetti, S. ;
Mergui-Roelvink, M. ;
Reyderman, L. ;
Copelu, W. ;
Wanders, J. ;
Jenner, A. ;
Edwards, G. ;
Schellens, J. H. ;
Voest, E. E. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[48]   Views of stroke survivors on impact of visual impairment. [J].
Rowe, F. J. .
CEREBROVASCULAR DISEASES, 2014, 37 :304-304
[49]   Sensory impairment as a predictor of 10-year mortality and functional impairment. [J].
Mui, S ;
Reuben, D ;
Damesyn, M ;
Greendale, G ;
Moore, A .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) :S19-S19
[50]   EFFECT OF FIMASARTAN ON PHARMACOKINETICS IN PATIENTS WITH RENAL IMPAIRMENT. [J].
Kim, S. ;
Shin, D. ;
Kim, Y. S. ;
Cho, S. H. ;
Jang, I. J. ;
Lee, H. ;
Yu, K. S. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 :S72-S72
12345